MA42175A1 - Pyrazolopyrimidine Derivatives as Btk Inhibitors for Cancer Treatment - Google Patents

Pyrazolopyrimidine Derivatives as Btk Inhibitors for Cancer Treatment

Info

Publication number
MA42175A1
MA42175A1 MA42175A MA42175A MA42175A1 MA 42175 A1 MA42175 A1 MA 42175A1 MA 42175 A MA42175 A MA 42175A MA 42175 A MA42175 A MA 42175A MA 42175 A1 MA42175 A1 MA 42175A1
Authority
MA
Morocco
Prior art keywords
cancer treatment
btk inhibitors
compounds
pyrazolopyrimidine derivatives
tyrosine kinase
Prior art date
Application number
MA42175A
Other languages
French (fr)
Other versions
MA42175B1 (en
Inventor
Nicolas Guisot
Original Assignee
Loxo Oncology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Loxo Oncology Inc filed Critical Loxo Oncology Inc
Priority claimed from PCT/GB2016/052897 external-priority patent/WO2017046604A1/en
Publication of MA42175A1 publication Critical patent/MA42175A1/en
Publication of MA42175B1 publication Critical patent/MA42175B1/en

Links

Abstract

La présente invention concerne de nouveaux composés. Les composés selon l'invention sont des inhibiteurs de tyrosine kinase. Plus particulièrement, les composés selon l'invention sont utiles comme inhibiteurs de la tyrosine kinase de bruton (btk). L'invention concerne également l'utilisation de ces composés pour traiter des états pathologiques qui peuvent être traités par l'inhibition de la tyrosine kinase de bruton, par exemple le cancer, des lymphomes, la leucémie et des maladies immunologiques.The present invention relates to novel compounds. The compounds according to the invention are tyrosine kinase inhibitors. More particularly, the compounds of the invention are useful as inhibitors of the crude tyrosine kinase (btk). The invention also relates to the use of these compounds for treating pathological conditions that can be treated by the inhibition of broncine tyrosine kinase, for example cancer, lymphomas, leukemia and immunological diseases.

MA42175A 2015-09-16 2016-09-16 Pyrazolopyrimidine derivatives as btk inhibitors for cancer treatment MA42175B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1516445.2A GB201516445D0 (en) 2015-09-16 2015-09-16 Compounds
PCT/GB2016/052897 WO2017046604A1 (en) 2015-09-16 2016-09-16 Pyrazolopyrimidine derivatives as btk inhibitors for the treatment of cancer

Publications (2)

Publication Number Publication Date
MA42175A1 true MA42175A1 (en) 2018-11-30
MA42175B1 MA42175B1 (en) 2021-06-30

Family

ID=54363286

Family Applications (1)

Application Number Title Priority Date Filing Date
MA42175A MA42175B1 (en) 2015-09-16 2016-09-16 Pyrazolopyrimidine derivatives as btk inhibitors for cancer treatment

Country Status (2)

Country Link
GB (1) GB201516445D0 (en)
MA (1) MA42175B1 (en)

Also Published As

Publication number Publication date
MA42175B1 (en) 2021-06-30
GB201516445D0 (en) 2015-10-28

Similar Documents

Publication Publication Date Title
MA49809A1 (en) Compounds used as kinase inhibitors
MX2018003351A (en) Pyrazolopyrimidine derivatives as btk inhibitors for the treatment of cancer.
EA202092590A1 (en) PYRIDAZINONES AS PARP7 INHIBITORS
EA202091709A1 (en) DNA PC INHIBITORS
CY1108927T1 (en) MITOTIC KINESIN SUSPENSIONS
DE60329756D1 (en) MITOTIC KINESINE HEMMER
DE60231439D1 (en) MITOTIC KINESINE HEMMER
DE60234278D1 (en) MITOTIC KINESINE HEMMER
DE60329990D1 (en) MITOTIC KINESINE HEMMER
ATE372341T1 (en) INHIBITORS OF MITOTIC KINESIN
EP2170337A4 (en) Novel triazolopyridazines
EA202091708A1 (en) DNA PC INHIBITORS
MX2021006619A (en) Tyrosine kinase inhibitors, compositions and methods there of.
PH12021550743A1 (en) Boron containing pde4 inhibitors
MX2023001296A (en) Compositions and methods for treating diseases and disorders.
NO20070589L (en) Mitotic kinesin inhibitors.
MA42988B1 (en) Spirocyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxamide
EA201890769A1 (en) 2,3,4,5-TETRAHYDROPYRIDIN-6-AMINE DERIVATIVES
MA42175A1 (en) Pyrazolopyrimidine Derivatives as Btk Inhibitors for Cancer Treatment
MA42871A1 (en) Compounds used as inhibitors of crude tyrosine kinase (btk)
ATE426605T1 (en) INHIBITORS OF MITOTIC KINESIN
EA202190902A1 (en) FATTY ACID SYNTHASE INHIBITION (FASN)
MA51297B1 (en) Quinazolinones as parp14 inhibitors
MA45367B1 (en) Tyrosine kinase inhibitors
EA202190690A1 (en) Boron-containing PDE4 inhibitors